Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...
"[People] had been developing Arabidopsis microarrays for a number of years, and these were some of the first papers that published high-quality data with real biological conclusions," says Chris Town ...
Welcome to the 6th annual Advances in Microarray Technology (AMT) conference where you will hear about the latest developments and applications in the rapidly expanding field of microarrays. This year ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback